REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Galvex, spol. s r.o. (Slovakia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Galvex, spol. s r.o. Profile Updated: April 14, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Galvex, spol. s r.o. is an enterprise in Slovakia, with the main office in Banska Bystrica. The enterprise operates in the Pharmaceutical Preparation Manufacturing industry. It was first established on July 24, 2001. 50 - 99 (2023) employees currently work for Galvex, spol. s r.o.. The company’s latest financial report indicates a net sales revenue increase of 14.62% in 2023. Its’ total assets recorded a negative growth of 3.65%. In 2023, Galvex, spol. s r.o.’s net profit margin decreased by 7.29%.

Headquarters
Jegorovova 37
Banska Bystrica; Banskobystricky; Postal Code: 97401

Contact Details: Purchase the Galvex, spol. s r.o. report to view the information.

Basic Information
Total Employees:
Purchase the Galvex, spol. s r.o. report to view the information.
Outstanding Shares:
Purchase the Galvex, spol. s r.o. report to view the information.
Registered Capital:
Purchase the Galvex, spol. s r.o. report to view the information.
Incorporation Date:
July 24, 2001
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Attorney
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Galvex, spol. s r.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
14.62%▲
Total operating revenue
13.1%▲
Operating profit (EBIT)
-68.14%▼
EBITDA
-41.39%▼
Net Profit (Loss) for the Period
-66.74%▼
Total assets
-3.65%▼
Total equity
2.14%▲
Operating Profit Margin (ROS)
-9.39%▼
Net Profit Margin
-7.29%▼
Return on Equity (ROE)
-4.34%▼
Debt to Equity Ratio
-6.26%▼
Quick Ratio
0.4%▲
Cash Ratio
0.07%▲

Similar companies

Johnson & Johnson, s.r.o.
 
Novartis Slovakia s.r.o.
Saneca Pharmaceuticals a. s.
 
HBM Pharma s.r.o.
Hartmann - Rico spol. s r.o.
 
BB Pharma s.r.o.
Pharmagal, spol. s.r.o.
 
G.V.Pharma, a.s.
Institute Europharm, s.r.o.
 
Vitalos s. r. o.
CMS Chemicals, s.r.o.
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo